Farrukh T. Awan
0000-0003-1813-9812
Publication & Citation Trends
Publications
0 total
POSTER: ABCL-1224 Updated Results From EPCORE NHL-6: Phase 2 Study of Subcutaneous Epcoritamab as Outpatient Treatment for 2L+ Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Cited by 0
Semantic Scholar
ABCL-1224: Updated Results From EPCORE NHL-6: Phase 2 Study of Subcutaneous Epcoritamab as Outpatient Treatment for 2L+ Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Cited by 0
Semantic Scholar
AML-117: A Phase 1b Study of Selinexor and Venetoclax in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Cited by 1
Semantic Scholar
POSTER: AML-117 A Phase 1b Study of Selinexor and Venetoclax in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Cited by 0
Semantic Scholar
ABCL-1254: Impact of β-Blockers on Outcomes Following Dose-Adjusted EPOCH Chemotherapy in Aggressive Non-Hodgkin Lymphoma (NHL)
Cited by 0
Semantic Scholar
POSTER: ABCL-1254 Impact of β-Blockers on Outcomes Following Dose-Adjusted EPOCH Chemotherapy in Aggressive Non-Hodgkin Lymphoma (NHL)
Cited by 0
Semantic Scholar
CLL-186 Interim Results From ASSURE: A Phase 3b Safety Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukemia
Cited by 1
Semantic Scholar
AC676, an Orally Bioavailable BTK Chimeric Degrader in Patients With B-cell Malignancies
Cited by 0
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(245)
Lymphoma Diagnosis and Treatment
(181)
CAR-T cell therapy research
(78)
Chronic Myeloid Leukemia Treatments
(65)
Immunodeficiency and Autoimmune Disorders
(40)
Affiliations
University of Iowa
University Medical Center Groningen
Inserm
University of Pittsburgh
Simmons University